Stockscreener 앱 받기
0.8216
3.01%
-0.0255
시간 외 거래:
.82
-0.0016
-0.19%
Biofrontera Inc 주식(BFRI)의 최신 뉴스
Biofrontera Warrants (BFRIW) Hold Flat at $0.01 as Trading Activity Remains SubduedStock Picks - https://www.siam.in/
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Biofrontera (NasdaqCM:BFRI) Stock Forecast & Analyst Predictions - Simply Wall Street
Form 8K Biofrontera Inc For: 14 September By Investing.com - Investing.com Nigeria
Form 8K Biofrontera Inc For: 14 September By Investing.com - Investing.com UK
The FDA approved the first and only light treatment for a skin cancer - Stock Titan
Biofrontera Warrants (BFRIW) Hold Near $0.02 as Sub-Penny Instrument Edges LowerFear Greed Index - careplusvn.com
Biofrontera Warrants (BFRIW) Hold Near $0.02 as Sub-Penny Instrument Edges LowerMomentum Factor - siam.in
Biofrontera Warrants (BFRIW) Hold Near $0.02 as Sub-Penny Instrument Edges LowerTrading Ideas - www.dars.gov.et
Biofrontera (NASDAQ:BFRI) Passes Minervini Trend Template With High-Growth Momentum - ChartMill
BFRI Q2 2026 Earnings: Loss Narrows Sharply, Delivering 53% EPS BeatEarnings Acceleration Picks - vinanet.vn
Biofrontera (BFRI) Jumps 6.71% to $1.59, Testing Key Resistance Near $1.67Common Gap - vinanet.vn
Biofrontera Inc. Warrants (BFRIW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Biofrontera (BFRI) Quarterly Figures: Profit Per Share Clears Its Benchmark on the Day; Share Move: Shares Show Little Net Change in Latest TradingRevenue Inflection Point - vinanet.vn
Biofrontera (BFRI) Q2 2026 Earnings Call Transcript - AOL.com
Biofrontera (BFRI) Q2 2026 Earnings Call Transcript - The Globe and Mail
Biofrontera (BFRI) Close and Levels: Posts a 6.67% Gain to $1.44 in the Current Update; Trading Range: Price Remains Between $1.37 Support and $1.51 Resistance on the DayCall Spread Alert - vinanet.vn
Biofrontera (BFRI) Close and Levels: Posts a 6.67% Gain to $1.44 in the Current Update; Trading Range: Price Remains Between $1.37 Support and $1.51 Resistance on the DayGamma Flip Level - dars.gov.et
Ziopharm: Q2 Earnings Snapshot - AOL.com
Biofrontera (BFRI) Climbs 3.17% to $1.30: Holding Above Key Support ZonePCR Divergence - vinanet.vn
Biofrontera Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Biofrontera Q2 2026 Earnings Call Transcript - marketbeat.com
Biofrontera Inc (BFRI) (Q2 2026) Earnings Call Highlights: Strong Ameluz Growth Drives Revenue ... - Yahoo Finance
Biofrontera Inc. (BFRI) lifts revenue yet flags going concern and ITC impact - Stock Titan
Biofrontera Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BFRI Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 6.4% Stock RallyEarnings Weakness Phase - vinanet.vn
Same Patent, Same Light- Director Vacates IPR Decision at Odds With ITC Decision - The National Law Review
Biofrontera earnings beat by $0.09, revenue topped estimates - Investing.com
Earnings call transcript: Biofrontera tops Q2 2026 estimates, shares jump 9.6% - Investing.com
BFRI: Record revenue growth, margin expansion, and strong pipeline offset ITC lamp restriction - TradingView
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Price to earnings forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc. (BFRI) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Biofrontera Inc For: 13 August By Investing.com - Investing.com Australia
Form 8K Biofrontera Inc For: 13 August By Investing.com - Investing.com Nigeria
BIOFRONTERA ($BFRI) Releases Q2 2026 Earnings - Quiver Quantitative
Form 8K Biofrontera Inc For: 13 August By Investing.com - Investing.com India
Biofrontera Reports Q2 2026 Revenue Up 33% to $12.0M, Gross Margin 80% - TradingView
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - The Manila Times
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - marketscreener.com
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - Yahoo Finance
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - GlobeNewswire
Biofrontera (BFRI) investor Rosalind discloses 9.9% stake and 9.99% blocker - Stock Titan
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Sees 51% Downside - Yahoo Finance
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Se - GuruFocus
Biofrontera Inc. Warrants (BFRIW) Hold Steady at $0.03 as Support and Resistance ConvergeMAMA Signal - dars.gov.et
Biofrontera Inc. Warrants (BFRIW) Hold Steady at $0.03 as Support and Resistance ConvergeInsider Sentiment - www.dars.gov.et
Biofrontera Inc. (BFRI) Stock Major Holders - Yahoo! Finance Canada
Price to sales forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc (BFRI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
5.26%
5.96%
자본화:
|
볼륨(24시간):